Cerebrolysin Injection (Cerebroprotein) | Used to Treat Strokes, Head Injuries, and Aprosexia in Dementia
Cerebrolysin Injection is used to treat strokes, head injuries, and aprosexia in dementia by enhancing nerve survival and preventing nerve damage. Cerebroprotein is an active ingredient that prvents neurons and improves memory, attention, and vigilance.
Product Overview
Cerebrolysin Injection (Cerebroprotein) is used to treat Alzheimer’s, dementia, stroke, and traumatic brain injuries by promoting neuronal repair and recovery. Cerebrolysin is a unique neurotrophic medication consisting of a concentrate of low-molecular-weight peptides and amino acids derived from purified porcine brain proteins. Unlike many standard neurological treatments, Cerebrolysin is designed to mimic the action of endogenous neurotrophic factors. It acts directly on the central nervous system to provide neuroprotection, promote neuroplasticity, and support the repair of damaged nerve cells. It is extensively utilized in the clinical management of various neurodegenerative and vascular neurological disorders.
Product Composition
- Active Ingredient: Cerebrolysin Concentrate (Cerebroprotein Hydrolysate)
- Components: A complex mixture of peptides and free amino acids
- Dosage Form: Solution for Injection/Infusion
- Strengths: Available in 10 ml ampoules
- Pharmacological Class: Neurotrophic agent / Nootropic
Product Specification
| Feature | Details |
| Primary Indication | Stroke, Dementia, & Traumatic Brain Injury |
| Mechanism Category | Neuroprotection & Neuroregeneration |
| Route of Administration | Intramuscular (IM) or Intravenous (IV) |
| Target Organ | Central Nervous System (CNS) |
| Storage | Store below 25°C; protect from light; do not freeze |
Mechanism of Action
- Neuroprotection: Protects neurons from the harmful effects of metabolic stress, such as hypoxia and excitotoxicity, by stabilizing the cellular membrane.
- Neuroregeneration: Stimulates the formation of new connections between nerve cells (synaptogenesis) and promotes the survival of existing neurons.
- Blood-Brain Barrier Penetration: The small molecular size of the peptides allows them to cross the blood-brain barrier effectively to reach target sites in the brain.
- Metabolic Optimization: Enhances the brain's aerobic energy metabolism and improves protein synthesis in aging or damaged brain cells.
- Apoptosis Inhibition: Acts to prevent programmed cell death (apoptosis) triggered by pathological conditions like ischemia or neurodegeneration.
Key Benefits
- Multimodal Action: Provides a comprehensive approach by simultaneously protecting, repairing, and optimizing brain tissue.
- Cognitive Enhancement: Clinically shown to improve memory, attention, and overall cognitive performance in patients with dementia.
- Stroke Recovery Support: Accelerates the rehabilitation process following an ischemic stroke by limiting the extent of tissue damage.
- Safe Profile: Generally well-tolerated with a long clinical history of use in specialized neurological care.
- Flexible Dosing: Can be administered via small intramuscular injections or larger intravenous infusions depending on the severity of the condition.
Precautions
General Precautions
- Cerebrolysin Injection (Cerebroprotein) should be administered only by a qualified healthcare professional
- Do not self-administer or adjust the dose without medical supervision
- Follow the prescribed dosage schedule strictly
- Monitor patient response during therapy as advised by the physician
Medical History Precautions
- Inform your doctor if you have epilepsy or a history of seizures
- Tell your doctor if you have severe kidney impairment
- Disclose any history of allergic reactions to peptide-based medicines
- Inform your doctor about any ongoing neurological conditions
Pregnancy and Breastfeeding Precautions
- Use during pregnancy only if clearly prescribed by a doctor
- Breastfeeding women should use only under medical supervision
Drug and Health Safety
| Condition / Situation | Precaution |
|---|---|
| Epilepsy or seizure disorders | May increase seizure risk; requires close monitoring |
| Kidney impairment | Dose adjustment may be required |
| Allergic tendency | Risk of hypersensitivity reactions |
| Acute neurological conditions | Requires careful clinical evaluation |
| Elderly patients | Should be used with caution under supervision |
Usage
Dosage and Administration
Professional Administration: This medication must be administered by a qualified healthcare professional. It is not intended for self-administration.
Intramuscular (IM) Use: Smaller volumes, typically up to 5 ml, can be given as a deep intramuscular injection.
Intravenous (IV) Injection: Doses between 5 ml and 10 ml may be administered via slow intravenous injection.
Intravenous (IV) Infusion: For larger doses (10 ml to 50 ml), the medication is diluted in a standard infusion solution (such as 0.9% saline) and administered as a slow drip over 15 to 60 minutes.
Course Duration: Treatment is usually administered in cycles. A standard cycle often involves daily injections for 10 to 20 consecutive days, followed by a treatment-free interval.
Administration Guidelines
| Scenario | Recommendation |
| Infusion Speed | Always administer slowly to minimize the risk of dizziness, heat sensations, or palpitations. |
| Preparation | The solution should be used immediately after opening the ampoule. Discard any unused portion. |
| Compatibility | Do not mix Cerebrolysin in the same infusion bottle with balanced amino acid solutions or lipid emulsions. |
| Renal Function | Use with extreme caution in patients with moderate kidney impairment; it is contraindicated in severe renal failure. |
Uses
Acute Ischemic Stroke: Used in the early stages of a stroke to protect brain tissue from further damage and improve functional recovery.
Traumatic Brain Injury (TBI): Assists in the rehabilitation process following head trauma by promoting nerve repair and reducing secondary inflammation.
Alzheimer’s Disease: Helps manage symptoms of dementia by improving cognitive functions, memory, and the patient's ability to perform daily activities.
Vascular Dementia: Specifically targets cognitive decline caused by impaired blood flow to the brain, helping to stabilize or improve mental clarity.
Cognitive Impairment: Used to treat general memory loss and concentration difficulties resulting from organic brain disorders.
Post-Operative Recovery: Occasionally used to support neurological function in patients recovering from complex neurosurgical procedures.
Spinal Cord Injury: In certain clinical settings, it is utilized as an adjunctive therapy to support the survival of spinal neurons following acute injury.
Side Effects
Cerebrolysin Injection (Cerebroprotein) is generally well tolerated when administered under medical supervision, but some patients may experience side effects.
Common Side Effects
- Headache
- Dizziness
- Nausea
- Fatigue or weakness
- Increased sweating
- Restlessness
Less Common Side Effects
- Loss of appetite
- Diarrhea or mild gastrointestinal discomfort
- Sleep disturbances (insomnia or drowsiness)
- Mild confusion (especially in elderly patients)
- Injection site reactions (pain, redness, or swelling)
Serious Side Effects
| Serious Condition | Symptoms |
|---|---|
| Allergic reaction | Rash, itching, swelling of face/lips/tongue, difficulty breathing |
| Severe neurological reaction | Agitation, confusion, or worsening neurological symptoms |
| Seizures (rare) | Convulsions or loss of consciousness |
| Severe hypersensitivity | Fever, chills, or systemic allergic response |
| Cardiovascular changes (rare) | Blood pressure fluctuations, palpitations |
Important Advice
- Administer only under medical supervision
- Report any signs of allergic reaction immediately
- Monitor neurological status during treatment
- Do not self-administer or adjust dosage
- Seek urgent medical care if seizures or severe reactions occur
FAQs
Q: What is Cerebrolysin used for?
A: It is a specialized medication used to treat various brain disorders, including ischemic and hemorrhagic strokes, traumatic brain injuries, and different forms of dementia, such as Alzheimer's disease.
Q: How is this medication administered?
A: Cerebrolysin must be administered by a healthcare professional. It is given either as an intramuscular (IM) injection for smaller doses or as an intravenous (IV) infusion (drip) for larger doses.
Q: How long does a typical treatment course last?
A: The duration varies based on the condition. For stroke or brain injury, it is often given daily for 10 to 20 days. For dementia, it may be administered in several cycles with breaks in between.
Q: Can I administer this injection at home?
A: No. This medication should only be administered in a clinical setting by trained medical staff to ensure proper technique and to monitor for any immediate reactions.
Q: Are there any contraindications?
A: Cerebrolysin should not be used in patients with severe kidney impairment (renal failure) or those with a history of status epilepticus (frequent seizures).
Q: What are the common side effects?
A: Most patients tolerate it well, but some may experience "infusion-related" symptoms such as dizziness, sweating, or a feeling of heat. Rare effects include mild agitation or insomnia.
Q: How soon can I expect to see improvements?
A: Results depend on the severity of the neurological damage. In acute cases like stroke, benefits may be observed during the initial course, while cognitive improvements in dementia typically appear over several treatment cycles.
Q: Can Cerebrolysin be mixed with other IV fluids?
A: It is compatible with standard solutions like 0.9% saline or Ringer’s solution. However, it should not be mixed with solutions that change the pH or contain lipids.
Q: Is it safe for elderly patients?
A: Yes, it is frequently used in elderly populations for the management of age-related cognitive decline and stroke recovery. Dosage adjustments are usually based on the specific clinical condition rather than age alone.
Interactions
Drug Interactions
| Medicine / Drug Class | Interaction Effect |
|---|---|
| Antidepressants | May enhance neuroactive effects; requires monitoring |
| MAO inhibitors | Potential additive neurological effects; use with caution |
| Anticonvulsants (antiepileptics) | May alter seizure threshold; careful monitoring required |
| Nootropic or neuroprotective agents | Possible additive effects on CNS activity |
| Sedatives or CNS depressants | May increase drowsiness or CNS-related effects |
Food and Lifestyle Interactions
- No significant food interactions are known
- Alcohol should be avoided as it may interfere with neurological recovery
- Maintain adequate hydration during therapy
Disease Interactions
- Epilepsy or seizure disorders may require close monitoring
- Severe renal impairment may affect drug clearance
- Acute neurological conditions need specialist supervision
- History of hypersensitivity may increase risk of allergic reactions
Important Clinical Considerations
- Inform your doctor about all medications and supplements before treatment
- Use only under strict neurological supervision
- Monitor for any changes in mood, cognition, or neurological status
- Avoid combining with other neuroactive treatments unless prescribed
- Discontinue and seek medical attention if severe allergic or neurological reactions occur
| Manufacturer | : | Sun Pharma, India |
| Trade Name | : | Cerebrolysin |
| Generic Search | : | Cerebroprotein |
| Strength | : | 10ml |
Latest Products
